Salvat International

At Salvat, we drive our business with a strong focus on #innovation, especially in Otorhinolaryngology, Ophthalmology and Gastroenterology. Each of our developments aims for a clear goal: to significantly improve people's quality of life. How do we do it? 🔍 We work on both internal projects and collaborations with public and private research groups, always ensuring therapeutic solutions. We offer our R&D services to companies interested in the potential of our patented technologies 🌐 All the details 👉 https://lnkd.in/dKjWu6xe

We are excited to share the fourth episode of our "Salvat Talks" video series! 🎥 🗣️ In this episode, Enrique Jiménez, our Medical Director, and Alberto Bueno, our Managing Director, discuss "R&D Investment and Pipeline." Discover how Salvat is advancing ophthalmology and otology through substantial investments in research and development, and explore our promising pipeline of future treatments. Click the video below to watch the full episode! 👇

What an amazing #CPHI2024 in Milan! We've had a fantastic time connecting with fellow pharmaceutical companies to explore potential opportunities. A big thank you from our Salvat team members to everyone who visited our booth. It was a pleasure to talk and connect with each of you! We look forward to seeing you at the next event. Stay tuned for more exciting updates and breakthroughs from Salvat.

🎥 In the third episode of our "Salvat Talks" video series, Enrique Jiménez, Salvat's Medical Director, discusses the advancements Salvat is making in post-surgical care through its nanoemulsion delivery technology, IMPACT-SVT® 👇

🔜 See you at #CPHI2024, the most important event in the #pharmaceutical sector! 📆 October 8 – 10 📍 Fiera Milano, Milan 📌 Booth: 14F20 If you're looking for product licensing opportunities or solutions for your #CDMO and #Manufacturing projects, come visit us! Our Business Development and Purchasing team will be happy to assist you🤝 Additionally, we’re excited to announce that we’ve been selected as finalists for the CPHI Pharma Awards in the Finished Formulation category! 🏆 Check all the details 🔗 https://lnkd.in/eXiKSGxi

We are delighted to share the second episode of our "Salvat Talks" video series! 🎥 🗣️ In this episode, Jörg Behrendt, our National Manager, and Enrique Jiménez, our Medical Director, discuss “Leaders in ENT Otic Clotrimazole.” Join us as we explore Salvat's pioneering role in the development and innovation of otic clotrimazole, and how we are advancing treatments in otolaryngology. Click the video below to watch the full episode! 👇

Today, we celebrate #WorldPharmacistsDay. At Salvat International, we want to recognize and thank all pharmacists for their indispensable role in healthcare. Your skill in managing medications and commitment to ensuring safety and effectiveness greatly improves patient care. We're committed to ongoing collaboration with pharmacists to enhance health outcomes for communities around the world. Thank you for always being there!

We are delighted to unveil the first episode of our new video series, "Salvat Talks"! 🎥 🗣️ In this inaugural episode, we welcome Alberto Bueno, our Managing Director, and Patricia Ferriot, our International and Business Development Director. The episode, titled "Internationalization at Pharma Salvat," delves into the dynamic journey of our company's global expansion. 🌍🔬 Learn from our experiences as we navigate the complexities of bringing pharmaceutical innovation to new international markets. This episode offers invaluable insights and inspiration for companies looking to expand their global footprint. Click the video below to watch the full episode! 👇

Our #clobetasol nanoemulsion is specifically formulated to address inflammation and pain following #ocular surgery 🌟🚀 🔬 Developed with our unique IMPACT-SVT® #technology, this treatment is the first ocular corticosteroid in a nanoemulsion form. It has been proven effective in extensive clinical trials involving over 400 patients in the U.S. 🏭 Produced with the Blow-Fill-Seal process, we guarantee the highest standards of #quality and #safety at our facilities in Miami and Madrid. Visit our website for more info 👁️ https://lnkd.in/gA8HsvTN

At Salvat, we are advancing the development of specialized treatments for #otomycosis with our Clotrimazole medication 🌟   Clotrimazole is the first and only treatment indicated for fungal otitis externa, with clinical trials conducted in Europe and the United States. Thanks to our focus on innovation, we have formulated this treatment in single-dose vials, ensuring it is effective, safe, easy to use, and well-tolerated by patients 👂   For more information 👉 https://lnkd.in/evvXfjbA